Lynne Maquat, PhD, recipient of the 2017 Vanderbilt Prize in Biomedical Science whose work has advanced our understanding of human gene expression, will deliver her Vanderbilt Prize lecture as part of the Flexner Discovery Lecture series on Nov. 29.

Stephen Baylin, MD, a trailblazer in the study of the epigenetics of cancer, will deliver the next Flexner Discovery Lecture on Thursday, Nov. 8. His lecture, sponsored by the Vanderbilt-Ingram Cancer Center, will begin at 4 p.m. in room 208 Light Hall.

Jeffrey Kahn, PhD, MPH, director of the Johns Hopkins Berman Institute of Bioethics, spoke about the role of bioethics in precision medicine during his recent Flexner Discovery Lecture.

Reining in the nation’s opioid epidemic will require diverse and innovative strategies ranging from drug discovery to “policy translation,” according to speakers at a recent Vanderbilt Faculty Cutting-edge Discovery Lecture.

Noted bioethicist Jeffrey Kahn, PhD, MPH, will deliver the next Flexner Discovery Lecture on Thursday, Sept. 27.

The first Flexner Discovery Lecture of the academic year featured presentations by two Vanderbilt faculty members.

Innovative strategies for addressing the nation’s opioid epidemic and its consequences will be discussed during a Cutting-edge Discovery Lecture on Sept. 13. The lecture will begin at 4 p.m. in room 208 Light Hall.